What the Community is Saying?
“Thank you for putting on another successful BSMA. The award and recognition is greatly appreciated. It was a special thrill for me to accept on behalf of all at Envirotainer that contributed. The content and attendees again delivered on the high level that is required to set BSMA apart, and the message will be carried back to my HQ in Sweden of the nice momentum and full wind in our sails.”
“I really thought the interaction and engagement of the audience was strong, Dave you did a great job of stimulating the audience with perspective, questions, and out of the box questions and challenges to the pharma industry to think differently. Innovation is a high motivator and getting senior leadership on board with it is critical and that seemed to be a clear theme at the conference.”
“The conference was full of energy this year. Over 200 attendees and thought provoking mix of company success stories, expert panel discussions, and wonderful networking. Lets keep driving focused on our mission of growing the supply chain excellence in the Biotech industry. We need to balance catering to larger companies and supporting those companies that are just developing their supply chain expertise.”
“The conference was remarkably open and geared towards sharing best known methods, something I have not observed in other parts of silicon valley. I found the Kite cell therapy key note very innovative and invigorating. I was also impressed that the supply chain is centered within the USA . In the semiconductor space as you know since the last 2 decades much of the cutting edge manufacturing has gone to Asia. I love the mission of the alliance which is centered on strategy, innovation and global community all for improving health and finding cures for patients.”
“What you’ve accomplished with the BSMA and the relevance of the topics and breakthrough pathways you promote is of considerable significance. It takes not only a deep acumen of the industry trend, but also a keen sense of the impact of those novel approaches, with close interdependency between hospital sites, complex logistics and unique cell therapy Manufacturing process. Thank you for spreading awareness in such timely and engaging way.”
“As biopharmaceutical process engineers-in-training at KGI, most of us are only exposed to the R&D, process development, quality and regulatory features of the industry. I’m sure that the other BSMA conference attendees in my cohort would agree that the experience has really opened our eyes to the supply chain aspect of the biotech industry. The supply chain was something we took for granted and therefore overlooked, but clearly it is one of the most important aspects of the industry.”